BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 29948360)

  • 1. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial resistance in Germany. Four years of antimicrobial resistance surveillance (ARS)].
    Noll I; Schweickert B; Abu Sin M; Feig M; Claus H; Eckmanns T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1370-6. PubMed ID: 23114435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
    Kunz Coyne AJ; Casapao AM; Isache C; Morales J; McCarter YS; Jankowski CA
    Microbiol Spectr; 2021 Oct; 9(2):e0046421. PubMed ID: 34704795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
    Tian L; Sun Z; Zhang Z
    BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in antimicrobial resistance in Israel, 2014-2017.
    Dickstein Y; Temkin E; Ish Shalom M; Schwartz D; Carmeli Y; Schwaber MJ
    Antimicrob Resist Infect Control; 2019; 8():96. PubMed ID: 31171967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Blood Culture Isolates and their Antibiogram in a Teaching hospital.
    Shrestha S; Amatya R; Shrestha RK; Shrestha R
    JNMA J Nepal Med Assoc; 2014; 52(193):692-6. PubMed ID: 26905550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
    Yang S; Xu H; Sun J; Sun S
    Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection in burn patients in a referral center in Colombia.
    Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
    Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of community-onset extended-spectrum β-lactamase-producing
    Richelsen R; Smit J; Anru PL; Schønheyder HC; Nielsen H
    Infect Dis (Lond); 2020 Aug; 52(8):547-556. PubMed ID: 32401562
    [No Abstract]   [Full Text] [Related]  

  • 16. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
    Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D
    Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India.
    Abhilash KP; Veeraraghavan B; Abraham OC
    J Assoc Physicians India; 2010 Dec; 58 Suppl():13-7. PubMed ID: 21563608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
    Nasa P; Juneja D; Singh O; Dang R; Singh A
    Eur J Intern Med; 2012 Mar; 23(2):192-5. PubMed ID: 22284253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.
    Leistner R; Gürntke S; Sakellariou C; Denkel LA; Bloch A; Gastmeier P; Schwab F
    Infection; 2014 Dec; 42(6):991-7. PubMed ID: 25100555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.